Presentation is loading. Please wait.

Presentation is loading. Please wait.

Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis Ross L. Levine,

Similar presentations


Presentation on theme: "Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis Ross L. Levine,"— Presentation transcript:

1 Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis Ross L. Levine, Martha Wadleigh, Jan Cools, Benjamin L. Ebert, Gerlinde Wernig, Brian J.P. Huntly, Titus J. Boggon, Iwona Wlodarska, Jennifer J. Clark, Sandra Moore, Jennifer Adelsperger, Sumin Koo, Jeffrey C. Lee, Stacey Gabriel, Thomas Mercher, Alan D’Andrea, Stefan Fröhling, Konstanze Döhner, Peter Marynen, Peter Vandenberghe, Ruben A. Mesa, Ayalew Tefferi, James D. Griffin, Michael J. Eck, William R. Sellers, Matthew Meyerson, Todd R. Golub, Stephanie J. Lee, D. Gary Gilliland Cancer Cell Volume 7, Issue 4, Pages 387-397 (April 2005) DOI: 10.1016/j.ccr.2005.03.023 Copyright © 2005 Elsevier Inc. Terms and Conditions Terms and Conditions

2 Figure 1 Cancer Cell 2005 7, 387-397DOI: (10.1016/j.ccr.2005.03.023) Copyright © 2005 Elsevier Inc. Terms and Conditions Terms and Conditions

3 Figure 2 Cancer Cell 2005 7, 387-397DOI: (10.1016/j.ccr.2005.03.023) Copyright © 2005 Elsevier Inc. Terms and Conditions Terms and Conditions

4 Figure 3 Cancer Cell 2005 7, 387-397DOI: (10.1016/j.ccr.2005.03.023) Copyright © 2005 Elsevier Inc. Terms and Conditions Terms and Conditions

5 Figure 4 Cancer Cell 2005 7, 387-397DOI: (10.1016/j.ccr.2005.03.023) Copyright © 2005 Elsevier Inc. Terms and Conditions Terms and Conditions


Download ppt "Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis Ross L. Levine,"

Similar presentations


Ads by Google